|
1
|
Tolar J, Teitelbaum SL and Orchard PJ:
Osteopetrosis. N Engl J Med. 351:2839–2849. 2004. View Article : Google Scholar
|
|
2
|
Stark Z and Savarirayan R: Osteopetrosis.
Orphanet J Rare Dis. 4:52009. View Article : Google Scholar
|
|
3
|
Loría-Cortés R, Quesada-Calvo E and
Cordero-Chaverri C: Osteopetrosis in children: a report of 26
cases. J Pediatr. 91:43–47. 1977.
|
|
4
|
Bollerslev J and Andersen PE Jr:
Radiological, biochemical and hereditary evidence of two types of
autosomal dominant osteopetrosis. Bone. 9:7–13. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Frattini A, Orchard PJ, Sobacchi C,
Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK,
Wallbrandt P, Zecca L, et al: Defects in TCIRG1 subunit of the
vacuolar proton pump are responsible for a subset of human
autosomal recessive osteopetrosis. Nat Genet. 25:343–346. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kornak U, Schulz A, Friedrich W, Uhlhaas
S, Kremens B, Voit T, Hasan C, Bode U, Jentsch TJ and Kubisch C:
Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause
infantile malignant osteopetrosis. Hum Mol Genet. 9:2059–2063.
2000.
|
|
7
|
Sobacchi C, Frattini A, Orchard P, Porras
O, Tezcan I, Andolina M, Babul-Hirji R, Baric I, Canham N, Chitayat
D, et al: The mutational spectrum of human malignant autosomal
recessive osteopetrosis. Hum Mol Genet. 10:1767–1773. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cleiren E, Bénichou O, Van Hul E, Gram J,
Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama
T, et al: Albers-Schönberg disease (autosomal dominant
osteopetrosis, type II) results from mutations in the ClCN7
chloride channel gene. Hum Mol Genet. 10:2861–2867. 2001.
|
|
9
|
Frattini A, Pangrazio A, Susani L,
Sobacchi C, Mirolo M, Abinun M, Andolina M, Flanagan A, Horwitz EM,
Mihci E, et al: Chloride channel ClCN7 mutations are responsible
for severe recessive, dominant, and intermediate osteopetrosis. J
Bone Miner Res. 18:1740–1747. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Del Fattore A, Peruzzi B, Rucci N, Recchia
I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M,
Luciani M, et al: Clinical, genetic, and cellular analysis of 49
osteopetrotic patients: implications for diagnosis and treatment. J
Med Genet. 43:315–325. 2006.
|
|
11
|
Supanchart C and Kornak U: Ion channels
and transporters in osteoclasts. Arch Biochem Biophys. 473:161–165.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kornak U, Kasper D, Bösl MR, Kaiser E,
Schweizer M, Schulz A, Friedrich W, Delling G and Jentsch TJ: Loss
of the ClC-7 chloride channel leads to osteopetrosis in mice and
man. Cell. 104:205–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Väänänen HK, Zhao H, Mulari M and Halleen
JM: The cell biology of osteoclast function. J Cell Sci.
113:377–381. 2000.
|
|
14
|
Ars E, Serra E, García J, Kruyer H, Gaona
A, Lázaro C and Estivill X: Mutations affecting mRNA splicing are
the most common molecular defects in patients with
neurofibromatosis type 1. Hum Mol Genet. 9:237–247. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
López-Bigas N, Audit B, Ouzounis C, Parra
G and Guigó R: Are splicing mutations the most frequent cause of
hereditary disease? FEBS Lett. 579:1900–1903. 2005.PubMed/NCBI
|
|
16
|
Yu T, Wang X, Ding Q, Fu Q, Dai J, Lu Y,
Xi X and Wang H: Using a minigene approach to characterize a novel
splice site mutation in human F7 gene causing inherited factor VII
deficiency in a Chinese pedigree. Haemophilia. 15:1262–1266. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pangrazio A, Pusch M, Caldana E, Frattini
A, Lanino E, Tamhankar PM, Phadke S, Lopez AG, Orchard P, Mihci E,
et al: Molecular and clinical heterogeneity in CLCN7 dependent
osteopetrosis report of 20 novel mutations. Hum Mutat.
31:E1071–E1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krawczak M, Reiss J and Cooper DN: The
mutational spectrum of single base-pair substitutions in mRNA
splice junctions of human genes: causes and consequences. Hum
Genet. 90:41–54. 1992. View Article : Google Scholar
|
|
19
|
Nakai K and Sakamoto H: Construction of a
novel database containing aberrant splicing mutations of mammalian
genes. Gene. 141:171–177. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chu K, Koller DL, Snyder R, Fishburn T,
Lai D, Waguespack SG, Foroud T and Econs MJ: Analysis of variation
in expression of autosomal dominant osteopetrosis type 2: searching
for modifier genes. Bone. 37:655–661. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pettersson U, Albagha OM, Mirolo M,
Taranta A, Frattini A, McGuigan FE, Vezzoni P, Teti A, van Hul W,
Reid DM, Villa A and Ralston SH: Polymorphisms of the CLCN7 gene
are associated with BMD in women. J Bone Miner Res. 20:1960–1967.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kornak U, Ostertag A, Branger S, Benichou
O and de Vernejoul MC: Polymorphisms in the CLCN7 gene modulate
bone density in postmenopausal women and in patients with autosomal
dominant osteopetrosis type II. J Clin Endocrinol Metab.
91:995–1000. 2006. View Article : Google Scholar : PubMed/NCBI
|
